Quantcast
Close Window
   
Welcome :o)
Welcome to another year exposing the harms of Johnson & Johnson products and the executives that care more about money than human health...
 
There really is a highly effective way to put an end to mass tort lawsuits: GET JOHNSON & JOHNSON AND SUBSIDIARY KNOWN DEFECTIVE, HARMFUL AND/OR TOXIC PRODUCTS OFF THE GLOBAL MARKET
 
This work is 100% independent. I am NOT a victim, NOT a lawyer, NOT paid by anyone other than visitors to the site. And no, I do not own any stock in Johnson & Johnson.
 
Emily.
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Glad to see you :o)
This web site currently has the attention of:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Gifts of support are always very much appreciated...
Thank you,
Emily
 
$.00   
 

Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Insiders and Berkshire Dump Johnson & Johnson JNJ Stock
Insider trading shows JNJ management selling and no buying for years and Berkshire dumped all of JNJ stock. Gee, wonder why? Maybe corruption, lawsuits, recalls and toxic products? Nah...

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, insider, trading, berkshire
Date Created/Edited: 2013, July 18
 

Most Recent Content....
Second Quarter 2017 Lawsuits Against Johnson & Johnson Stable, BUT NOT All-Inclusive (2017, August 8)
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
Johnson & Johnson Tylenol Massacre
From dead babies to killer liver damage to autism to dimentia, harmful effects of Tylenol creates a massive flood of permanently injured and sometimes dead, victims.
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Fastest Growing Segment of Johnson & Johnson Is... (2016, November 15)
Growing over 29% in 2016, this is definitely the fastest growing segment of Johnson & Johnson!
johnson & johnson, J&J, JNJ, 2016, lawsuit, lawsuits, tort, liability
 
Third Quarter 2016 Lawsuits Against Johnson & Johnson Still Exploding! Now 99,000! (2016, November 15)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 99,000.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Wealthy Most at Risk for Harm by Johnson & Johnson and Subsidiary Products (2016, August 22)
If you make over $100,000 a year, you are far more likely than lower incomes to become a victim of a Johnson & Johnson and/or subsidiary product.
healthcare, cost, co-pay, risk, deductable, insurance, victim, salary
 
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 82,200 to 90,700 (2016, August 4)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Johnson and Johnson Janssen Xarelto Slaughter (2016, July 8)
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Over 500 DEAD, 7,100 lawsuits already. Lovely, eh?
false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
 
This Convinced THREE Juries That Johnson and Johnson Talc Increases Ovarian Cancer (2016, May 14)
One very simple fact convinced THREE juries that Johnson & Johnson talc increases risk of developing ovarian cancer.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, ovarian, talc
 
I love this quote on the Securities and Exchange Commission Form 4 web page for Johnson & Johnson
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
Considering the SEC Form 4 shows that management is not buying JNJ stock, and has been selling since 2011, it seems like a very good indication that Johnson & Johnson executives are not very confident in the future of JNJ. In addition, Berkshire and Hathaway, the conglomerate holding company, has dropped Johnson & Johnson from their portfolio. Well, it's really starting to look like all the problems at Johnson & Johnson are finally affecting management and investor confidence in the company.
 
If you take a look at the SEC Form 4 for Johnson & Johnson, it is apparent that management across the board has been dumping JNJ stock without buying for almost two years. Executives from the Controller, to the CEO to the retired CEO,the management is pulling their money out of the company. Isn't that a 'bad thing'? In addition, unlike other, similar industries, insider trading is - $87,806,045.
 

Warren Buffett's Berkshire Hathaway started off in March 2012 with 30 million shares of JNJ. By June 30, 2012 had sold off almost one third of his JNJ stock. That seems like a lot to me. Berkshire continued to dump JNJ with dropping over 29 million shares of JNJ stock in less than a year. After dropping more than 95% of JNJ stock, the value of the stock they still hold makes up only $34 million of their multi-billion dollar portfolio. During the first quarter of 2013, Berkshire dumped the last of JNJ from Warren Buffet's portfolio.

 
Yep, looks like a whole lot of bailing going on, and we're not talking hay.
 
Maybe it is becoming apparent to Billy, Dorksky, Dominic, Russell, James, and Mr. Warren Buffet, that JNJ stock finally has more outgoing in recalls, litigation, settlements, fines, restituttion and lawsuits against it than Johnson & Johnson can handle with current income and cash reserves.
 
Wait, I think I saw that coming about a year ago - and a lot more have been added since then.
 
Resources:
1. US SEC (Current). SEC Form 4 Insider Trading United States Securities Exchange Commission. Retrieved from http://www.secform4.com/insider-trading/200406.htm
 
2. Jon C. Ogg (2013, May 13). Berkshire Hathaway 2013 Annual Meeting Focus: Buffett Portfolio Changes 24/7 Wall St.. Retrieved from http://247wallst.com/banking-finance/2013/05/03/berkshire-hathaway-2013-annual-meeting-focus-buffett-portfolio-changes/
 
3. Bloomberg News (2012, August 14). Buffett's Berkshire Hathaway cuts Johnson & Johnson holdings, adds oil NJ.com. Retrieved from http://www.nj.com/business/index.ssf/2012/08/buffetts_berkshire_hathaway_cu.html
 
4. Alex Crippen (2012, November 14). Buffett's Berkshire Sells Most of J&J and GE Stakes CNBC. Retrieved from http://www.cnbc.com/id/49827014
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries